Trial · NCT00521014
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT, SGPT | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 5 | 13 | 5 |
| other | AST, SGOT | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 2 | 13 | 2 |
| other | Albumin, low (hypoalbuminemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| other | Amylase | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 3 | 13 | 3 |
| other | Creatinine | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| other | Glucose, high (hyperglycemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 6 | 13 | 6 |
| other | Hemoglobin | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 13 | 13 | 13 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 13 | 13 | 13 |
| other | Lymphopenia | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 13 | 13 | 13 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 13 | 13 | 13 |
| other | Phosphate, low (hypophosphatemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 10 | 13 | 10 |
| other | Platelets | Blood and lymphatic system disorders | Relapsed Follicular Lymphoma Patients | 13 | 13 | 13 |
| other | Potassium, high (hyperkalemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| other | Potassium, low (hypokalemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| serious | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| serious | Inf norm ANC/gr1/2 | Infections and infestations | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| serious | Obstruction, GI- Gallbladder | Gastrointestinal disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
| serious | Pain - Buttock | General disorders | Relapsed Follicular Lymphoma Patients | 1 | 13 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00521014/events